Clinical Trial Update: Imuran (Azathioprine) Dose-Ranging Study in Crohn's Disease [Phase 3]

View source ↗

Summary

A Phase 3 dose-ranging study of azathioprine (Imuran) in Crohn's disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• IMURAN (Azathioprine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Crohn's Disease | Phase 3 | Status: TERMINATED